PharmAthene Inc (NYSE MKT LLC:PIP)

1.63
Delayed Data
As of 3:59pm ET
 +0.01 / +0.62%
Today’s Change
1.19
Today|||52-Week Range
2.59
-9.94%
Year-to-Date
SECTOR
Commercial Services
INDUSTRY
Miscellaneous Commercial Services
MARKET CAP
$103.1M

Company Description

PharmAthene, Inc. operates as a biodefense company, which is engaged in the development and commercialization of medical countermeasures against biological and chemical threats. Its product development programs include SparVax, a second generation recombinant protective antigen anthrax vaccine; Valortim, a fully human monoclonal antibody for the prevention and treatment of anthrax infection; and Recombinant BChE, countermeasures for nerve agent poisoning by organophosphorous compounds, including nerve agents and pesticides. The company was founded in March 2001 and is headquartered in Annapolis, MD.

Contact Information

PharmAthene, Inc.
1 Park Place
Annapolis Maryland 21401
P:(410) 269-2600
Investor Relations:
(410) 269-2610

Employees

Shareholders

Individual stakeholders36.42%
Mutual fund holders3.64%
Other institutional29.10%

Top Executives

John M. GillPresident, Chief Executive Officer & Director
Linda L. ChangChief Financial Officer & Senior Vice President
Arthur Y. ElliottChief Scientific Officer
Jeffrey Michael JonesVice President-Corporate Development
Stacey JurchisonDirector-Corporate Communications

To view my watchlist

Not a member yet?

Sign up now for a free account